Targeting biomolecular condensation and protein aggregation against cancer
Biomolecular condensates, membrane-less entities arising from liquid–liquid phase
separation, hold dichotomous roles in health and disease. Alongside their physiological …
separation, hold dichotomous roles in health and disease. Alongside their physiological …
Gain-of-function mutant p53 in cancer progression and therapy
Abstract p53 is a key tumor suppressor, and loss of p53 function is frequently a prerequisite
for cancer development. The p53 gene is the most frequently mutated gene in human …
for cancer development. The p53 gene is the most frequently mutated gene in human …
A guide to studying protein aggregation
JAJ Housmans, G Wu, J Schymkowitz… - The FEBS …, 2023 - Wiley Online Library
Disrupted protein folding or decreased protein stability can lead to the accumulation of
(partially) un‐or misfolded proteins, which ultimately cause the formation of protein …
(partially) un‐or misfolded proteins, which ultimately cause the formation of protein …
Multicomponent peptide assemblies
DM Raymond, BL Nilsson - Chemical Society Reviews, 2018 - pubs.rsc.org
Self-assembled peptide nanostructures have been increasingly exploited as functional
materials for applications in biomedicine and energy. The emergent properties of these …
materials for applications in biomedicine and energy. The emergent properties of these …
Dual Tumor Microenvironment Remodeling by Glucose‐Contained Radical Copolymer for MRI‐Guided Photoimmunotherapy
Aberrant glucose metabolism and immune evasion are recognized as two hallmarks of
cancer, which contribute to poor treatment efficiency and tumor progression. Herein, a novel …
cancer, which contribute to poor treatment efficiency and tumor progression. Herein, a novel …
p53 isoforms and their implications in cancer
M Vieler, S Sanyal - Cancers, 2018 - mdpi.com
In this review we focus on the major isoforms of the tumor-suppressor protein p53,
dysfunction of which often leads to cancer. Mutations of the TP53 gene, particularly in the …
dysfunction of which often leads to cancer. Mutations of the TP53 gene, particularly in the …
Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
L Palanikumar, L Karpauskaite, M Al-Sayegh… - Nature …, 2021 - nature.com
Missense mutations in p53 are severely deleterious and occur in over 50% of all human
cancers. The majority of these mutations are located in the inherently unstable DNA-binding …
cancers. The majority of these mutations are located in the inherently unstable DNA-binding …
p53 amyloid aggregation in cancer: function, mechanism, and therapy
J Li, M Guo, L Chen, Z Chen, Y Fu, Y Chen - Experimental Hematology & …, 2022 - Springer
Similar to neurodegenerative diseases, the concept that tumors are prion like diseases has
been proposed in recent years. p53, the most well-known tumor suppressor, has been …
been proposed in recent years. p53, the most well-known tumor suppressor, has been …
Aberrant phase separation and cancer
K Taniue, N Akimitsu - The FEBS journal, 2022 - Wiley Online Library
Eukaryotic cells are intracellularly divided into numerous compartments or organelles, which
coordinate specific molecules and biological reactions. Membrane‐bound organelles are …
coordinate specific molecules and biological reactions. Membrane‐bound organelles are …
Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands
EC Petronilho, MM Pedrote, MA Marques… - Chemical …, 2021 - pubs.rsc.org
Mutant p53 tends to form aggregates with amyloid properties, especially amyloid oligomers
inside the nucleus, which are believed to cause oncogenic gain-of-function (GoF). The …
inside the nucleus, which are believed to cause oncogenic gain-of-function (GoF). The …